![](/img/cover-not-exists.png)
A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group
Isakoff, Michael S., Goldsby, Robert, Villaluna, Doojduen, Krailo, Mark D., Hingorani, Pooja, Collier, Anderson, Morris, Carol D., Kolb, E. Anders, Doski, John J., Womer, Richard B., Gorlick, Richard,Language:
english
Journal:
Pediatric Blood & Cancer
DOI:
10.1002/pbc.27524
Date:
October, 2018
File:
PDF, 322 KB
english, 2018